Reflection Asset Management Buys New Position in Danaher Corporation $DHR

Reflection Asset Management acquired a new stake in shares of Danaher Corporation (NYSE:DHR) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 6,055 shares of the conglomerate’s stock, valued at approximately $1,386,000. Danaher accounts for about 1.0% of Reflection Asset Management’s portfolio, making the stock its 29th largest holding.

Several other hedge funds and other institutional investors have also recently modified their holdings of DHR. JPL Wealth Management LLC bought a new stake in shares of Danaher during the third quarter valued at approximately $25,000. Elevated Capital Advisors LLC bought a new position in shares of Danaher during the fourth quarter worth $26,000. WFA of San Diego LLC purchased a new position in Danaher during the second quarter valued at $26,000. ANTIPODES PARTNERS Ltd purchased a new position in Danaher during the third quarter valued at $27,000. Finally, Hilton Head Capital Partners LLC bought a new stake in Danaher in the 4th quarter valued at $27,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Stock Performance

DHR stock opened at $177.74 on Friday. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The firm has a market cap of $125.80 billion, a price-to-earnings ratio of 34.38, a PEG ratio of 2.26 and a beta of 0.81. The business’s fifty day simple moving average is $179.62 and its two-hundred day simple moving average is $203.07. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last issued its earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The business had revenue of $5.95 billion for the quarter, compared to the consensus estimate of $6 billion. During the same period in the prior year, the firm earned $1.88 EPS. The company’s revenue for the quarter was up 3.7% compared to the same quarter last year. Analysts predict that Danaher Corporation will post 8.45 earnings per share for the current year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio is presently 30.95%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the company. Morgan Stanley decreased their target price on Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. Piper Sandler started coverage on Danaher in a report on Thursday, June 11th. They set a “neutral” rating and a $200.00 price target for the company. Argus reduced their price objective on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research note on Friday, April 24th. Wells Fargo & Company decreased their price objective on Danaher from $240.00 to $212.00 and set an “equal weight” rating on the stock in a report on Wednesday, April 22nd. Finally, Wall Street Zen downgraded Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, April 25th. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and a consensus target price of $233.61.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.